Stockreport

Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study [Yahoo! Finance]

Onconetix, Inc.  (ONCO) 
PDF cancer survival rates through early detection, announces today that the company has successfully developed accurate and precise assays to measure targeted proteins for i [Read more]